Article Details

Pulmatrix (NASDAQ:PULM) Cut to "Sell" at Zacks Investment Research

Retrieved on: 2021-01-30 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

Pulmatrix (NASDAQ:PULM) Cut to "Sell" at Zacks Investment Research. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 779,839 shares of the biotechnology company's stock valued at $928,000 after buying an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up